Creating meaningful cut-scores for Neuro-QOL measures of fatigue, physical functioning, and sleep disturbance using standard setting with patients and providers

Quality of Life Research

Volumn 24, Issue 3, 2015, Pages 575-589

  Cook, Karon F ^a   Victorson, David E ^a   Cella, David ^a   Schalet, Benjamin D ^a   Miller, Deborah ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Interpretation of HRQOL data; Item response theory (IRT); Multiple sclerosis; Neurology; Psychometric methods scaling

Indexed keywords

ADULT; AGED; COMPLICATION; FATIGUE; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; QUALITY OF LIFE; SELF REPORT; SLEEP; SLEEP DISORDER; YOUNG ADULT;

ADULT; AGED; FATIGUE; FEMALE; FOCUS GROUPS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; SELF REPORT; SLEEP; SLEEP WAKE DISORDERS; YOUNG ADULT;

EID: 84924192127     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-014-0790-9     Document Type: Article

References (54)

1. Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A. R., & Zalutsky, R. (2007). How common are the “common” neurologic disorders? Neurology,68(5), 326–337.
2. Hopman, W. M., Coo, H., Edgar, C. M., McBride, E. V., Day, A. G., & Brunet, D. G. (2007). Factors associated with health-related quality of life in multiple sclerosis. Canadian Journal of Neurological Sciences,34(2), 160–166.
3. Miller, D. M., & Allen, R. (2010). Quality of life in multiple sclerosis: Determinants, measurement, and use in clinical practice. Current Neurology and Neuroscience Reports,10(5), 397–406.
4. Mitchell, A. J., Benito-Leon, J., Rivera-Navarro, J., & Morales-Gonzalez, J. M. (2004). Quality of life is not favorable for most patients with multiple sclerosis. Archives of Neurology, 61(11), 1807–1808. Author reply 1808.
5. Kargiotis, O., Paschali, A., Messinis, L., & Papathanasopoulos, P. (2010). Quality of life in multiple sclerosis: Effects of current treatment options. International Review of Psychiatry,22(1), 67–82.
6. Miller, D., Rudick, R. A., & Hutchinson, M. (2010). Patient-centered outcomes: Translating clinical efficacy into benefits on health-related quality of life. Neurology,74(Suppl 3), S24–S35.
7. Cella, D., Gershon, R., Lai, J. S., & Choi, S. (2007). The future of outcomes measurement: Item banking, tailored short-forms, and computerized adaptive assessment. Quality of Life Research,16(Suppl 1), 133–141.
8. Gershon, R. C., Cella, D., Fox, N. A., Havlik, R. J., Hendrie, H. C., & Wagster, M. V. (2010). Assessment of neurological and behavioural function: The NIH Toolbox. Lancet Neurology,9(2), 138–139.
9. U S Department of Health and Human Services, F. D. A. (2010). The patient reported outcomes (PRO) Consortium. From Retrieved December 3, 2011, from http://www.fda.gov/AboutFDA/PartnershipsCollaborations/PublicPrivatePartnershipProgram/ucm231129.htm.
10. Cella, D., Lai, J. S., Nowinski, C. J., Victorson, D., Peterman, A., Miller, D., et al. (2012). Neuro-QOL: Brief measures of health-related quality of life for clinical research in neurology. Neurology,78(23), 1860–1867.
11. Gershon, R. C., Lai, J. S., Bode, R., Choi, S., Moy, C., Bleck, T., et al. (2012). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research,21(3), 475–486.
12. Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA,273(1), 59–65.
13. Anastasi, A. (1988). Psychological testing (6th ed.). New York, NY: Macmillian Publishing Company.
14. Jensen, M. P., Smith, D. G., Ehde, D. M., & Robinsin, L. R. (2001). Pain site and the effects of amputation pain: Further clarification of the meaning of mild, moderate, and severe pain. Pain,91(3), 317–322.
15. Paul, S. M., Zelman, D. C., Smith, M., & Miaskowski, C. (2005). Categorizing the severity of cancer pain: Further exploration of the establishment of cutpoints. Pain,113(1–2), 37–44.
16. Serlin, R. C., Mendoza, T. R., Nakamura, Y., Edwards, K. R., & Cleeland, C. S. (1995). When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain,61(2), 277–284.
17. Zelman, D. C., Dukes, E., Brandenburg, N., Bostrom, A., & Gore, M. (2005). Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy. Pain,115(1–2), 29–36.
18. Zelman, D. C., Smith, M. Y., Hoffman, D., Edwards, L., Reed, P., Levine, E., et al. (2004). Acceptable, manageable, and tolerable days: Patient daily goals for medication management of persistent pain. Journal of Pain and Symptom Management,28(5), 474–487.
19. Zelman, D. C., Hoffman, D. L., Seifeldin, R., & Dukes, E. M. (2003). Development of a metric for a day of manageable pain control: Derivation of pain severity cut-points for low back pain and osteoarthritis. Pain,106(1–2), 35–42.
20. Given, B., Given, C. W., Sikorskii, A., Jeon, S., McCorkle, R., Champion, V., et al. (2008). Establishing mild, moderate, and severe scores for cancer-related symptoms: How consistent and clinically meaningful are interference-based severity cut-points? Journal of Pain and Symptom Management,35(2), 126–135.
21. Hays, R. D., Reise, S., & Calderon, J. L. (2012). How much is lost in using single items? Journal of General Internal Medicine,27(11), 1402–1403.
22. Buckendahl, C., Smith, R., Impara, J., & Plake, B. (2002). A comparison of Angoff and Bookmark standard setting methods. Journal of Educational Measurement,39(4), 253–263.
23. Huynh, H. (2010). Psychometric aspects of item mapping for criterion-referenced interpretation and bookmark standard setting. Journal of Applied Measurement,11(1), 91–98.
24. Lewis, D. M., Mitzel, H. C., & Green, D. R. (1996). Standard setting: A bookmark approach. In D. R. Green (Chair), IRT-based standard-setting procedures utilizing behavioral anchoring (symposium), Council of Chief State School Officers National Conference on Large-scale Assessment, Phoenix, AZ.
25. Cizek, G. J. (1993). Reconsidering standards and criteria. Journal of Educational Measurement,30(2), 93–106.
26. Perie, M. (2005). The Angoff and bookmark methods: Presentation at the annual meeting of the National Council on Measurement in Education. Montreal: National Council on Measurement in Education.
27. Zieky, M. J., Perie, M., & Livingston, S. A. (2008). Cutscores: A manual for setting standards of performance on educational and occupational tests. Princeton, NJ: Educational Testing Service.
28. Messick, S. (1998). Test validity: A matter of consequence. Social Indicators Research,45(1–3), 35–44.
29. Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001). Quality of life in multiple sclerosis: The impact of depression, fatigue and disability. Multiple Sclerosis,7(5), 340–344.
30. Coleman, C. I., Sidovar, M. F., Roberts, M. S., & Kohn, C. (2013). Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis. PLoS ONE,8(1), e54756.
31. Mills, R. J., & Young, C. A. (2011). The relationship between fatigue and other clinical features of multiple sclerosis. Multiple Sclerosis,17(5), 604–612.
32. Yozbatiran, N., Baskurt, F., Baskurt, Z., Ozakbas, S., & Idiman, E. (2006). Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients. Journal of the Neurological Sciences,246(1–2), 117–122.
33. Cella, D., Choi, S., Garci, A. S., Cook, K. F., Rosenbloom, S., Lai, J.-S., et al. (2014). Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment. Quality of Life Research. doi:10.1007/s11136-014-0732-6.
34. Cella, D., Choi, S., Rosenbloom, S., Surges, Tatum, D., Garcia, S., et al. (2008). A Novel IRT-based case-ranking approach to derive expert standards for symptom severity (paper presentation), International Society for Quality of Life Research Annual Scientific Meeting. Montevideo, Uruguay.
35. (NINDS), N. I. o. N. D. a. S. (2010). User manual for the quality of life in neurological disorders (Neuro-QOL) Measures. Version 1.0.
36. Team, R. D. C. (2008). A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. ISBN 3-900051-07-0. http://www.R-project.org.
37. Choi, S. W., Schalet, B. D., Cook, K. F., & Cella, D. (2014). Establishing a common metric for depressive symptoms: Linking BDI-II, CES-D, and PHQ-9 to PROMIS depression. Psychological Assessment,26(2), 513–527.
38. Schalet, B. D., Cook, K. F., Choi, S. W., & Cella, D. (2014). Establishing a common metric for anxiety symptoms: Linking GAD-7, MASQ, and PANAS to PROMIS anxiety. Journal of Anxiety Disorders,28(1), 88–96.
39. Wikipedia. List of most common surnames in North America. Retrieved 02/04/2014, from http://en.wikipedia.org/wiki/List_of_most_common_surnames_in_North_America.
40. Shepard, L. A. (1979). Setting standards. In M. A. Bunda & J. R. Sanders (Eds.), Practices and problems in competency-based measurement (pp. 72–88). Washington, DC: National Council on Measurement in Education.
41. Lampic, C., & Sjoden, P. O. (2000). Patient and staff perceptions of cancer patients’ psychological concerns and needs. Acta Oncologica,39(1), 9–22.
42. Radowsky, J. S., Baines, L., Howard, R. S., Shriver, C. D., Buckenmaier, C. C., I. I. I., & Stojadinovic, A. (2012). Pain ratings by patients and their providers of radionucleotide injection for breast cancer lymphatic mapping. Pain Medicine,13(5), 670–676.
43. Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., et al. (2006). Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: Results of a questionnaire-based study. The lancet Oncology,7(11), 903–909.
44. McColl, E., Junghard, O., Wiklund, I., & Revicki, D. A. (2005). Assessing symptoms in gastroesophageal reflux disease: How well do clinicians’ assessments agree with those of their patients? American Journal of Gastroenterology,100(1), 11–18.
45. Lazarus, R. S., & Folkman, S. (1987). Transactional theory and research on emotions and coping. European Journal of Personality,1, 141–169.
46. Salander, P., Bergenheim, T., & Henriksson, R. (1996). The creation of protection and hope in patients with malignant brain tumours. Social Science and Medicine,42(7), 985–996.
47. Burgess, C., Morris, T., & Pettingale, K. W. (1988). Psychological response to cancer diagnosis–II. Evidence for coping styles (coping styles and cancer diagnosis). Journal of Psychosomatic Research,32(3), 263–272.
48. Carver, C. S., Pozo, C., Harris, S. D., Noriega, V., Scheier, M. F., Robinson, D. S., et al. (1993). How coping mediates the effect of optimism on distress: A study of women with early stage breast cancer. Journal of Personality and Social Psychology,65(2), 375–390.
49. Dembo, T., Leviton, G. L., & Wright, B. A. (1956). Adjustment to misfortune; a problem of social-psychological rehabilitation. Artificial Limbs,3(2), 4–62.
50. Cizek, G. J. (2012). An introduction to contemporary standard setting. In G. J. Cizek (Ed.), Setting performance standards (2nd ed., pp. 3–14). New York, NY: Routledge.
51. Calvert, M., Draper, H., & Kyte, D. (2014). Patient-reported outcome alert monitoring—reply. JAMA,311(4), 420–421.
52. Thombs, B. D., Ells, C., & Black, L. (2014). Patient-reported outcome alert monitoring. JAMA,311(4), 420.
53. Deshpande, P. R., Rajan, S., Sudeepthi, B. L., & Abdul Nazir, C. P. (2011). Patient-reported outcomes: A new era in clinical research. Perspectives in Clinical Research,2(4), 137–144.
54. Brettschneider, C., Luhmann, D., & Raspe, H. (2011). Informative value of patient reported outcomes (PRO) in health technology assessment (HTA). GMS Health Technology Assessment, 7, Doc01.